The Institute of Medicine report, which pressed for the elimination of the 510(k) process for clearing medical devices, is a disappointment, said Covidien CEO Joe Almeida. The report failed to achieve the goals that the FDA wanted the IOM to deliver when it was commissioned by the agency in 2009, he said.

Related Summaries